Safety assessment of Bifidobacterium longum JDM301 based on complete genome sequences

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 5

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 7, 2012; 18(5): 479-488
Published online Feb 7, 2012. doi: 10.3748/wjg.v18.i5.479

Table 2 Minimum inhibitory concentration values of 16 antibiotics for Bifidobacterium longum JDM301

Antibiotics	Minimum inhibitory concentration (mg/L)
Ciprofloxacin	> 32
Amikacin	> 256
Gentamicin	> 256
Bacitracin	26.67
Streptomycin	170.67
Vancomycin	0.9
Amoxicillin	0.064
Cephalothin	1.33
Chloramphenicol	0.25
Erythromycin	0.04
Ampicillin	0.058
Cefotaxime	0.19
Rifampicin	0.074
Tetracycline	8
Imipenem	0.19
Trimethoprim-sulphamethoxazol	1.83

Citation: Wei YX, Zhang ZY, Liu C, Malakar PK, Guo XK. Safety assessment of Bifidobacterium longum JDM301 based on complete genome sequences. World J Gastroenterol 2012; 18(5): 479-488
URL: https://www.wjgnet.com/1007-9327/full/v18/i5/479.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i5.479

Wei YX, Zhang ZY, Liu C, Malakar PK, Guo XK. Safety assessment of Bifidobacterium longum JDM301 based on complete genome sequences. World J Gastroenterol 2012; 18(5): 479-488 [PMID: 22346255 DOI: 10.3748/wjg.v18.i5.479]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.